Search results
Results From The WOW.Com Content Network
1 Coccidia in dogs. ... and a dog will usually suffer no long-lasting negative effects. ... This page was last edited on 15 December 2023, ...
Cystoisospora canis, previously known as Isospora canis, is a microscopic, coccidian parasite that causes an intestinal tract infection in dogs. [2] The intestinal tract infection is coccidiosis caused by a protozoa (one-celled organisms) called coccidia. [3]
Coccidia Coccidia oocysts in a ... a group of medications that stop coccidia from reproducing. In dogs and cats, ... This page was last edited on 17 June 2024, at 19: ...
Sulfadimethoxine (or sulphadimethoxine, trade names Di-Methox or Albon) is a long-lasting sulfonamide antimicrobial medication used in veterinary medicine. It is used to treat many infections, including respiratory, urinary tract, enteric, and soft tissue infections [3] and can be given as a standalone or combined with ormetoprim to broaden the target range. [2]
In addition to being an important cause of cattle abortions, [7] neosporosis is a significant disease in dogs throughout the world. [18] If the disease is caught early, dogs may be successfully treated with clindamycin and other antiprotozoan drugs. [18] However, the disease is often fatal to young puppies. [18]
Toltrazuril is widely used in veterinary medicine to treat coccidiosis in various animals, including poultry, pigs, cattle, sheep, and companion animals like dogs and cats. It is often administered as a single dose or in a series of doses depending on the severity of the infection and the species being treated.
Discoid lupus erythematosus is an uncommon autoimmune disease of the skin in dogs. It does not progress to systemic lupus erythematosus in dogs. The most common initial symptom is scaling and loss of pigment on the nose. [34] Juvenile cellulitis, also known as puppy strangles, is a disease that affects puppies. Its cause is unknown, but it is ...
Ponazuril (), sold by Merial, Inc., [1] now part of Boehringer Ingelheim, [2] under the trade name Marquis (15% w/w ponazuril), is a drug currently approved for the treatment of equine protozoal myeloencephalitis (EPM) in horses, caused by coccidia Sarcocystis neurona.